Ileal brake
BiologicalProcessThe ileal brake is a physiological feedback mechanism by which unabsorbed nutrients in the small intestine triggers the release of satiety hormones that suppress appetite.
Where beauty meets biology
14 entities found starting with I Clear filters
The ileal brake is a physiological feedback mechanism by which unabsorbed nutrients in the small intestine triggers the release of satiety hormones that suppress appetite.
Chronic low-grade sterile inflammation accumulating with age through senescence, cGAS-STING, and NF-κB amplification — impairing tissue repair and driving structural skin ageing.
Low-spin blood preparation preserving platelets, leucocytes, and stem cells within a fibrin matrix that sustains growth factor release over 7-14 days.
A β‑cell–derived anabolic hormone that regulates glucose uptake, lipid storage, and tissue growth, with chronic hyperinsulinaemia producing metabolic effects before overt hyperglycaemia.
A state of reduced insulin responsiveness driven by DAG–PKC signalling and impaired fuel switching, linking metabolic overload to systemic glucose dysregulation.
The PI3K–AKT signalling pathway triggered by insulin receptor activation that drives glucose uptake, suppresses hepatic glucose output, and restrains adipose lipolysis.
A growth factor produced primarily by dermal fibroblasts and dermal papilla cells, with roles spanning fibroblast proliferation, keratinocyte migration, collagen stabilisation, and angiogenesis.
The body's outermost organ system, comprising the skin and its appendages: hair, nails, sebaceous glands, and sweat glands.
Inflammatory cytokine that suppresses production of barrier proteins including filaggrin and claudin-1.
IL‑33 is an epithelial‑derived “alarmin” cytokine released from stressed or damaged barrier tissues, including keratinocytes in the skin.
Inflammatory cytokine that suppresses barrier protein production, perpetuating barrier dysfunction during inflammatory skin conditions.
A pleiotropic cytokine with context-dependent pro- and anti-inflammatory effects determined by which receptor complex mediates signalling.
A fructooligosaccharide prebiotic fermented by S. epidermidis to support SCFA‑driven acidification, AMP tone, and barrier integrity while forming a hygroscopic film that reduces TEWL.
Topical actives that trigger TRP‑channel‑mediated neurogenic inflammation to produce transient lip swelling; effects are short‑lived and increase barrier disruption with repeated use.